ELNORA— Our Community Foundation has announced the second-semester Teaching Innovator grant recipients. North Daviess ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) ...

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood ...

Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking ...

TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the resear ...

BRIDGEWATER, NJ / ACCESS Newswire / January 27, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...

Teodorescu and in 2nd place to Lorraine McCormack Presenting authors must place their posters on display between midday and 2.00p.m. on the day of presentation ... high in which to display a summary ...

If you're a corporate worker, a student, or simply an education professional, you'll know how important presentations can be. But sometimes, we're in a time crunch, and it’s not always feasible ...

We list the best free presentation software, to make it simple and easy to create professional presentations without a subscription to Microsoft PowerPoint. While PowerPoint is the market leader ...

If you understand how the human brain decides what to pay attention to—and what to ignore—your public speaking and presentation skills will soar. I recently contacted John Medina, a cognitive ...

We closely analyze the services, check their features & openly share our testing methods with everyone. Creating presentations that stand out can be a real challenge, especially when you're short on ...